English | 简体中文 | 繁體中文 | 한국어
Share:
Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act

SAMPO PLC          STOCK EXCHANGE RELEASE       20 March 2017 at 2:50 pm

Disclosure Under Chapter 9 Section 5 of the Securities Market Act

Sampo plc (business code 0142213-3) has today received a disclosure under Chapter 9, Section 5 of the Securities Markets Act, according to which the total number of voting rights related to Sampo A shares (ISIN: FI009003305) owned directly or through financial instruments by BlackRock, Inc. (USA tax ID 32-0174421) and its funds decreased on 17 March 2017 below five (5) per cent of all votes. In addition, the Sampo A shares owned directly by BlackRock, Inc. and its funds decreased below five (5) per cent of all Sampo plc shares.

Sampo's share capital comprises 560,000,000 shares, of which 558,800,000 are A shares and 1,200,000 are B shares. Each A share entitles its holder to one (1) vote and each B share to five (5) votes. Thus, the total number of votes is 564,800,000.

Total positions of BlackRock, Inc and its funds subject to the notification:

% of shares and voting rights (total of A)% of shares and voting rights through financial instruments (total of B)Total of both in % (A+B)
Resulting situation on the date on which threshold was crossed or reached 4.98% shares

Below 5% voting rights
0.05% shares

Below 5% voting rights
5.03% shares

Below 5% voting rights
Positions of previous notification

5.02% shares

4.98% voting rights
0.05% shares

0.05% voting rights
5.07% shares

5.03% voting rights

Notified details of the resulting situation on the date on which the threshold was crossed:

A: Shares and voting rights:

Class/type of shares
ISIN code
Number of shares and voting rights% of shares and voting rights
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
FI0009003305 27,860,501 shares
Below 5% voting rights
4.98% shares
Below 5% voting rights
SUBTOTAL A 27,860,501 shares
Below 5% voting rights
4.98% shares
Below 5% voting rights

B: Financial instruments according to SMA 9:6a:

Type of financial
instrument
Expiration dateExercise/
Conversion Period
Physical or
cash settlement
Number of shares
and voting rights
% of shares and
voting rights
Securities Lent N/A N/A Physical 57,085 shares
Below 5% voting rights
0.01% shares
Below 5% voting rights
CFD N/A N/A Cash 223,664 shares
Below 5% voting rights
0.04% shares
Below 5% voting rights
SUBTOTAL B 280,749 shares
Below 5% voting rights
0.05% shares
Below 5% voting rights

SAMPO PLC

Jarmo Salonen
Head of Investor Relations and Group Communications
tel. +358 10 516 0030

Distribution:
Nasdaq Helsinki
London Stock Exchange
The principal media
Financial Supervisory Authority
www.sampo.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sampo Oyj via Globenewswire

Copyright © Thomson Reuters 2017. All rights reserved.
 Subscribe RSS Feed  
Press Releases
Nordic American Tankers Limited (NYSE:NAT) - Renewal and Filing of Shelf Registration Statement  
June 23, 2017 18:58 ET
NEJM publishes full analysis of Rydapt® (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML)  
June 23, 2017 18:00 ET
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial  
June 23, 2017 16:45 ET
Novo Nordisk A/S: CHMP adopts positive opinion for EU label update of Victoza® based on the LEADER trial  
June 23, 2017 13:40 ET
Medtronic Announces 7 Percent Increase in Cash Dividend  
June 23, 2017 12:45 ET
Sequa Petroleum N.V. Funding Update  
June 21, 2017 00:03 ET
AIR Worldwide Releases Updated Earthquake Model for the United States  
June 19, 2017 18:13 ET
Schrader Cellars Entrusts Constellation Brands with Highly-Coveted, Critically-Acclaimed Wine Portfolio  
June 17, 2017 04:33 ET
Kymab Group Ltd: Kymab appoints Dr Martin Nicklasson as Non-Executive Chair  
June 16, 2017 16:03 ET
NANOBIOTIX : new translational data presented at ASTRO, NCI AND SITC'S Immunotherapy Workshop  
June 16, 2017 03:53 ET
More News >>
Copyright © 2017 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: